Page 2 - Nasdaq Aveo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Equities analysts expect that AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO – Get Rating) will report earnings per share of ($0.26) for the current fiscal quarter, Zacks reports. Two analysts have made estimates for AVEO Pharmaceuticals’ earnings, with the lowest EPS estimate coming in at ($0.27) and the highest estimate coming in at ($0.25). AVEO Pharmaceuticals posted earnings […]

StockNews.com began coverage on shares of AVEO Pharmaceuticals (NASDAQ:AVEO – Get Rating) in a note issued to investors on Thursday. The firm set a “hold” rating on the biopharmaceutical company’s stock. Other research analysts have also issued research reports about the stock. Zacks Investment Research upgraded shares of AVEO Pharmaceuticals from a “sell” rating to […]

AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO – Get Rating) – Analysts at SVB Leerink upped their Q1 2022 earnings per share (EPS) estimates for shares of AVEO Pharmaceuticals in a note issued to investors on Monday, March 14th. SVB Leerink analyst A. Berens now anticipates that the biopharmaceutical company will earn ($0.27) per share for the quarter, […]

AVEO Pharmaceuticals (NASDAQ:AVEO – Get Rating) issued its earnings results on Monday. The biopharmaceutical company reported ($0.21) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.08, Fidelity Earnings reports. AVEO Pharmaceuticals had a negative return on equity of 105.47% and a negative net margin of 225.54%. During the same […]

Research analysts at Jonestrading initiated coverage on shares of AVEO Pharmaceuticals (NASDAQ:AVEO – Get Rating) in a research note issued to investors on Monday, The Fly reports. The brokerage set a “buy” rating on the biopharmaceutical company’s stock. AVEO has been the topic of a number of other reports. StockNews.com upgraded AVEO Pharmaceuticals from a […]